Found: 10
Select item for more details and to access through your institution.
Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications.
- Published in:
- Phytotherapy Research, 2024, v. 38, n. 7, p. 3564, doi. 10.1002/ptr.8229
- By:
- Publication type:
- Article
Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage.
- Published in:
- Molecules, 2020, v. 25, n. 23, p. 5719, doi. 10.3390/molecules25235719
- By:
- Publication type:
- Article
Advances in experimental models of rheumatoid arthritis.
- Published in:
- European Journal of Immunology, 2023, v. 53, n. 1, p. 1, doi. 10.1002/eji.202249962
- By:
- Publication type:
- Article
Progress on the study of the anticancer effects of artesunate.
- Published in:
- Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13011
- By:
- Publication type:
- Article
Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 5, p. 5386, doi. 10.3892/ol.2017.6844
- By:
- Publication type:
- Article
Matrine Suppresses Proliferation and Invasion of SGC7901 Cells through Inactivation of PI3K/Akt/uPA Pathway.
- Published in:
- Annals of Clinical & Laboratory Science, 2016, v. 46, n. 5, p. 457
- By:
- Publication type:
- Article
Erratum to "Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease".
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2022, p. 1, doi. 10.1155/2022/9782896
- By:
- Publication type:
- Article
Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2022, p. 1, doi. 10.1155/2022/4576679
- By:
- Publication type:
- Article
Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2022, p. 1, doi. 10.1155/2022/4576679
- By:
- Publication type:
- Article
Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.
- Published in:
- Clinical & Translational Oncology, 2018, v. 20, n. 9, p. 1145, doi. 10.1007/s12094-018-1833-4
- By:
- Publication type:
- Article